The diverse modes of regulation and the occurrence of the post-transcriptional modifications of BCL11A pre-mRNA suggest a very complex way of controlling BCL11A expression levels, which is most likely dependent on the type of cancer and possibly on the histological type of the same tumor. Here, BCL11A is linked to cancer.